Akums Drugs & Pharmaceuticals Ltd
₹761.15
+28.00
(+3.82%)
as on
🔔 Earnings Alert
Akums Drugs & Pharmaceuticals Q2 net profit more than doubled to ₹112.8 crore; revenue rose 31.9% to ₹1,342.3 crore with EBITDA margin expansion.
What are INDmoney investors doing with Akums Drugs & Pharmaceuticals shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-54%
Searches for Akums Drugs & Pharmaceuticals on INDmoney have decreased by 54% over the last 30 days.
Among the most traded stocks
211th
Akums Drugs & Pharmaceuticals was the 211th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
37 days
INDmoney investors hold Akums Drugs & Pharmaceuticals shares for an average of 37 days.
Key Events for Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals Stock Performance
as on November 3, 2026 at 9:31 pm IST
Day's Low
Day's High
₹735.30₹806.45
3.40%
Downside
5.95%
Upside
52 Week's Low
52 Week's High
₹409.30₹838.8046.23%
Downside
10.20%
Upside
Akums Drugs & Pharmaceuticals share price movements today
- Previous Close
- ₹733.15
- Open
- ₹774.00
- Volume
- 18.59L
- Upper Circuit
- ₹806.45
- Lower Circuit
- ₹659.85
- Day's Low - High
- ₹735.30 - ₹806.45
- 52 Week Low - High
- ₹409.30 - ₹838.80
Akums Drugs & Pharmaceuticals Historical Returns
- 1 Month Return
- -8.51 %
- 3 Month Return
- + 7.63 %
- 1 Year Return
- + 56.77 %
- 3 Year Return
- -7.92 %
- 5 Year Return
- -7.92 %
Akums Drugs & Pharmaceuticals Fundamentals
as on November 3, 2026 at 4:01 pm IST
Market Cap
₹11,539.34 Cr
Return on Equity (ROE)
4.72
PE Ratio (TTM)
30.86
Return on capital employed (ROCE)
6.48
Industry PE ratio
52.06
Beta (LTM)
0.83
P/B Ratio
2.94
Dividend Yield
0.63
PEG Ratio
10.12
Quarterly Earnings Growth YOY
168.31
EPS (TTM)
16.75
Book Value
216.41
Akums Drugs & Pharmaceuticals Stock Valuation
as on November 3, 2026 at 4:01 pm IST
Akums Drugs & Pharmaceuticals in the last 5 years
Lowest (18.75x)
April 7, 2025
Today (30.86x)
November 2, 2026
Industry (52.06x)
November 2, 2026
Highest (66.86x)
August 19, 2024
Today’s Price to Earnings Ratio: 30.86x
Akums Drugs & Pharmaceuticals Technical Analysis
Track how Akums Drugs & Pharmaceuticals technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -0.03 | |
CCI (20) | 326.09 | |
RSI (14) | 38.89 | Neutral |
Momentum (10) | -4.9 | |
ADI (14) | 17.9 | Neutral |
Ultimate Oscillator (7,14,28) | 37.44 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 761.79 | |
EMA (20) | 761.18 | |
VWMA (20) | 761.41 | |
SMA (50) | 761.04 | |
EMA (50) | 759.05 | |
SMA (200) | 748.77 | Bullish |
EMA (200) | 751.29 | Bullish |
KAMA (200) | 760.77 | |
DEMA (200) | 755.7 | Bullish |
Akums Drugs & Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Akums Drugs & Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 11,539.34 | -1.58% | 0.62 | 256 | 4,359 | |
| NA | 3,097.08 | -9.68% | 0.69 | -8 | 1,368 | |
| NA | 145.22 | 18.01% | 0.00 | 3 | 30 | |
| BUY | 2,721.74 | -11.67% | 0.70 | -49 | 1,712 | |
| NA | 122.90 | 66.46% | 0.73 | 11 | 248 |
Market expectation of Akums Drugs & Pharmaceuticals Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
100.00%
Buy
0.00%
Hold
0.00%
Sell
Akums Drugs & Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Akums Drugs & Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Akums Drugs & Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Akums Drugs & Pharmaceuticals
Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Akums Drugs & Pharmaceuticals
Sorted by largest increase in holding, month-over-month.
No buying activity data available right now
Mutual Funds Exiting Akums Drugs & Pharmaceuticals
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
 ICICI Prudential Healthcare Fund Direct Growth | ₹122.15 Cr | ₹14.83 Cr (-10.82%) | 1.91% |
Akums Drugs & Pharmaceuticals Corporate Actions
View detailed summary of the earnings and dividend history of Akums Drugs & Pharmaceuticals.
Akums Drugs & Pharmaceuticals Ltd Earnings Results
Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 176.73% since last year same period to ₹112.85Cr in the Q2 2026-2027. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 12.84% jump in its net profits since last 3-months.
Read MoreAkums Drugs & Pharmaceuticals Ltd Dividends May,2026
In the quarter ending March 2026, Akums Drugs & Pharmaceuticals Ltd has declared dividend of ₹2.00 per share on 14 May 2026 - translating a dividend yield of 0.41%.
Read More about Dividends
Indices Featuring Akums Drugs & Pharmaceuticals Stock
Check stock indices that include Akums Drugs & Pharmaceuticals.
Insights on Akums Drugs & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, AKUMS stock has moved up by 56.8%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.91% to 4.50% in Sep 2026 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 75.26% of holdings in Sep 2026 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 9.77% to 7.58% in Sep 2026 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 6.66% to 6.43% in Sep 2026 quarter
About Akums Drugs & Pharmaceuticals Ltd
Revenue: ₹1,342.39Cr as on September 2026 (Q2 FY27)
Net Profit: ₹114.57Cr as on September 2026 (Q2 FY27)
Listing date: 06 Aug, 2024
| Organisation | Akums Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs
What is Akums Drugs & Pharmaceuticals share price today?
Akums Drugs & Pharmaceuticals share price today stands at ₹761.15 as on at the close of the market. Akums Drugs & Pharmaceuticals share today touched a day high of ₹806.45 and a low of ₹735.3.
What is the 52 week high and 52 week low range for Akums Drugs & Pharmaceuticals share?
Akums Drugs & Pharmaceuticals touched a 52 week high of ₹838.8 and a 52 week low of ₹409.3. Akums Drugs & Pharmaceuticals share price today i.e. is closed at ₹761.15, which is -9.26% down from its 52 week high and 85.96% up from its 52 week low.
What is Akums Drugs & Pharmaceuticals's market capitalisation today?
Akums Drugs & Pharmaceuticals market capitalisation is ₹11,539.34 Cr as on .
How to buy Akums Drugs & Pharmaceuticals shares?
To buy Akums Drugs & Pharmaceuticals shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for AKUMS or Akums Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Akums Drugs & Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Akums Drugs & Pharmaceuticals trading volume today?
Akums Drugs & Pharmaceuticals trading volume is 18.59L as on . This means that 18.59L shares of Akums Drugs & Pharmaceuticals were bought and sold on the stock market during today's trading session.